Literature DB >> 15673432

Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.

Katsumi Tsuchiya1, Hisao Tajima, Toyoyasu Kuwae, Takao Takeshima, Toshiya Nakano, Masaharu Tanaka, Katsuyoshi Sunaga, Yoko Fukuhara, Kenji Nakashima, Eisaku Ohama, Hideki Mochizuki, Yoshikuni Mizuno, Nobuo Katsube, Ryoichi Ishitani.   

Abstract

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein; however, previous studies by our group and others have demonstrated that GAPDH is a general mediator initiating one or more apoptotic cascades. Our most recent findings have elucidated that an expression of a pro-apoptotic protein GAPDH is critically regulated at the promoter region of the gene. Apoptotic signals for its subsequent aggregate formation and nuclear translocation are controlled by the respective functional domains harboured within its cDNA component. In this study, coexpression of GAPDH with either wild-type or mutant (A53T) alpha-synuclein and less likely with beta-synuclein in transfected COS-7 cells was found to induce Lewy body-like cytoplasmic inclusions. Unlike its full-length construct, the deleted mutant GAPDH construct (C66) abolished these apoptotic signals, disfavouring the formation of inclusions. The generated inclusions were ubiquitin- and thioflavin S-positive appearing fibrils. Furthermore, GAPDH coimmunoprecipitated with wild-type alpha-synuclein in this paradigm. Importantly, immunohistochemical examinations of post mortem materials from patients with sporadic Parkinson's disease revealed the colocalized profiles immunoreactive against these two proteins in the peripheral zone of Lewy bodies from the affected brain regions (i.e. locus coeruleus). Moreover, a quantitative assessment showed that about 20% of Lewy bodies displayed both antigenicities. These results suggest that pro-apoptotic protein GAPDH may be involved in the Lewy body formation in vivo, probably associated with the apoptotic death pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673432     DOI: 10.1111/j.1460-9568.2005.03870.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  18 in total

Review 1.  Single-gene disorders: what role could moonlighting enzymes play?

Authors:  Ganesh Sriram; Julian A Martinez; Edward R B McCabe; James C Liao; Katrina M Dipple
Journal:  Am J Hum Genet       Date:  2005-04-22       Impact factor: 11.025

2.  Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde.

Authors:  Brigitte C Vanle; Virginia R Florang; Daryl J Murry; Arturo L Aguirre; Jonathan A Doorn
Journal:  Biochem Biophys Res Commun       Date:  2017-08-19       Impact factor: 3.575

3.  Characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase early amyloid-like oligomers and their implication in α-synuclein aggregation.

Authors:  Clarisa M Torres-Bugeau; César L Ávila; Rita Raisman-Vozari; Dulce Papy-Garcia; Rosangela Itri; Leandro R S Barbosa; Leonardo M Cortez; Valerie L Sim; Rosana N Chehín
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

4.  Structural characterization of heparin-induced glyceraldehyde-3-phosphate dehydrogenase protofibrils preventing α-synuclein oligomeric species toxicity.

Authors:  César L Ávila; Clarisa M Torres-Bugeau; Leandro R S Barbosa; Elisa Morandé Sales; Mohand O Ouidja; Sergio B Socías; M Soledad Celej; Rita Raisman-Vozari; Dulce Papy-Garcia; Rosangela Itri; Rosana N Chehín
Journal:  J Biol Chem       Date:  2014-03-26       Impact factor: 5.157

5.  Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-β Amyloidogenesis in Alzheimer Disease.

Authors:  Masanori Itakura; Hidemitsu Nakajima; Takeya Kubo; Yuko Semi; Satoshi Kume; Shusaku Higashida; Akihiro Kaneshige; Mitsuru Kuwamura; Naoki Harada; Akinori Kita; Yasu-Taka Azuma; Ryoichi Yamaji; Takashi Inui; Tadayoshi Takeuchi
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

Review 6.  Thiol-based redox switches in eukaryotic proteins.

Authors:  Nicolas Brandes; Sebastian Schmitt; Ursula Jakob
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

Review 7.  Lessons learned from protein aggregation: toward technological and biomedical applications.

Authors:  César L Avila; Silvina Chaves; Sergio B Socias; Esteban Vera-Pingitore; Florencia González-Lizárraga; Cecilia Vera; Diego Ploper; Rosana Chehín
Journal:  Biophys Rev       Date:  2017-09-13

8.  Glyceraldehyde-3-phosphate dehydrogenase aggregate formation participates in oxidative stress-induced cell death.

Authors:  Hidemitsu Nakajima; Wataru Amano; Takeya Kubo; Ayano Fukuhara; Hideshi Ihara; Yasu-Taka Azuma; Hisao Tajima; Takashi Inui; Akira Sawa; Tadayoshi Takeuchi
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

9.  Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase.

Authors:  Andre L Samson; Anja S Knaupp; Itamar Kass; Oded Kleifeld; Emilia M Marijanovic; Victoria A Hughes; Chris J Lupton; Ashley M Buckle; Stephen P Bottomley; Robert L Medcalf
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

10.  Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease.

Authors:  Mark H Chin; Wei-Jun Qian; Haixing Wang; Vladislav A Petyuk; Joshua S Bloom; Daniel M Sforza; Goran Laćan; Dahai Liu; Arshad H Khan; Rita M Cantor; Diana J Bigelow; William P Melega; David G Camp; Richard D Smith; Desmond J Smith
Journal:  J Proteome Res       Date:  2008-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.